In conclusion, the transcription factor RUNX1 plays an important role in multiple solid tumors and is highly expressed in ovarian cancer, in which it plays a key role, indicating that RUNX1 has the potential as a biomarker for the diagnosis and treatment of ovarian cancer. Here, RUNX1 is linked to ovarian carcinoma.